mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-15 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-15 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-13 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-13 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-13 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-12 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-12 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-12 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
8e-12 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-11 |